Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

21

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

21 results for “Self-medication”

Learn how ShareScore rates datasets ↗
zenodo40/100

Self-medication for anxiety symptoms in the context of COVID-19, in users who go to a drugstore in Los Olivos, Lima-2021

<p><strong>Background:</strong> To determine the relationship between self-medication and anxiety symptoms in the context of COVID-19, in users who go to a drugstore in Los Olivos, Lima 2021.</p> <p><strong>Methods:</strong> The research method was deductive, basic and with a quantitative approach; the design used was non-experimental, descriptive, correlational, cross-sectional, and prospective. Spearman&#39;s Rho analysis was performed to validate the hypothesis.</p> <p><strong>Results:</strong> 384 users were evaluated, finding 93.5% aged 18-59 years, of whom 53.4% were female, 42.7% had completed high school, 57.8% were single and 51.6% presented physical symptoms, preferably muscular tension accompanied by pain, 60.7% presented behavioral symptoms, highlighting unusual sadness in the face of COVID-19 and 70.1% presented cognitive symptoms with greater frequency of concern about contracting COVID-19. In addition, the greater the symptoms of anxiety, the higher the self-medication increased from 9.0% to 21.1%, a similar case was evidenced in self-medication on their own initiative where the increase was from 7.5% to 33.3%; likewise, self-medication without medical prescription increased from 15.8% to 47.7%, the consumption of anxiolytics or antidepressants increased from 0.8% to 26.3% caused by the symptoms of anxiety.</p> <p><strong>Conclusion:</strong> It was determined that there is a moderate relationship between self-medication and anxiety symptoms in the context of COVID-19, in users who go to a drugstore in Los Olivos, Lima 2021.</p> <p><strong>Keywords:</strong> Self-medication, prescription, anxiety, depression, COVID-19.</p> <p><strong>Background:</strong> To determine the relationship between self-medication and anxiety symptoms in the context of COVID-19, in users who go to a drugstore in Los Olivos, Lima 2021.</p> <p><strong>Methods:</strong> The research method was deductive, basic and with a quantitative approach; the design used was non-experimental, descriptive, correlational, cross-sectional, and prospective. Spearman&#39;s Rho analysis was performed to validate the hypothesis.</p> <p><strong>Results:</strong> 384 users were evaluated, finding 93.5% aged 18-59 years, of whom 53.4% were female, 42.7% had completed high school, 57.8% were single and 51.6% presented physical symptoms, preferably muscular tension accompanied by pain, 60.7% presented behavioral symptoms, highlighting unusual sadness in the face of COVID-19 and 70.1% presented cognitive symptoms with greater frequency of concern about contracting COVID-19. In addition, the greater the symptoms of anxiety, the higher the self-medication increased from 9.0% to 21.1%, a similar case was evidenced in self-medication on their own initiative where the increase was from 7.5% to 33.3%; likewise, self-medication without medical prescription increased from 15.8% to 47.7%, the consumption of anxiolytics or antidepressants increased from 0.8% to 26.3% caused by the symptoms of anxiety.</p> <p><strong>Conclusion:</strong> It was determined that there is a moderate relationship between self-medication and anxiety symptoms in the context of COVID-19, in users who go to a drugstore in Los Olivos, Lima 2021</p> <p>&nbsp;</p>

opencc-by-4.0Jun 2022View details →
zenodo36/100

Data set for survey questionnaires to assess self-medication practices

<p>This is pubmed and web of science data sets for a review on self medication survey questionnaires.&nbsp;</p>

opencc-zeroApr 2016View details →
zenodo36/100

Assessment of Self-Medication Practices and Safety Profile of Medicines Utilisation among Pregnant Women attending Antenatal Clinics in Freetown, Sierra Leone: A Multicentre Cross-Sectional Descriptive Study

<p><strong><span>Background: </span></strong><span>Despite the potential fetal and maternal risks of self-medication, studies on self-medication practice and the safety profile of medicines used during pregnancy are scarce in our setting. This study determined the self-medication practice and safety profile of medicines used among pregnant women.</span></p> <p><strong><span>Methods: </span></strong><span>This cross-sectional study was conducted in face-to-face interviews among 345 pregnant women at three hospitals in Sierra Leone. Data were analyzed using descriptive statistics and binary logistic regression to <span>determine the prevalence and associated factors of self-medication. </span></span></p> <p><strong><span>Results: </span></strong><span>A total of 345 pregnant women participated in the study. The prevalence of self-medication among pregnant women with conventional and/or herbal medicine was </span><span>132 (38.3%)</span><span>. Also, 93 (75%) of the conventional medicines (CMs) were categorized as probably safe, of which paracetamol 36 (29.0%) was commonly used, followed by amoxicillin 23 (18.5%) and antimalarials 22 (17.7%) for common illnesses such as </span><span>headache 30 (25.4%), </span><span>urinary tract infection </span><span>23 (19.4%)<span> and malaria 22 (18.6%). The common reason for self-medication was previous experience with the disease 24 (27.3%). </span><em>Luffa acutangula</em> 19 (30.2%) <span>was the most used herbal medicine (HM), </span>and Oedema 30 (47.6%) was the most reported ailment. <span>Among the HM users,</span> 34 (54.0%)<span> believe they are more effective than CMs. Secondary school education (AOR = 2.128, 95%CI = 1.191 &ndash; 3.804, p = 0.011), tertiary education (AOR = 2.915, 95%CI = 1.104 &ndash; 7.693, p = 0.031), monthly income of greater than NLe 1,000 (AOR = 4.084, 95% CI = 1.269 &ndash; 13.144, p = 0.018), and perceived maternal illness (AOR = 0.367, CI = 0.213 &ndash; 0.632, p = &lt;0.001) were predictors of self-medication.</span></span></p> <p><strong><span>Conclusion: </span></strong><span>Self-medication practice was highly prevalent and was associated with educational status, monthly income, and maternal illness during pregnancy. Therefore, intervention programs should be designed and implemented to minimize the practice and risk associated with self-medication among pregnant women.</span></p>

opencc-by-4.0Apr 2024View details →
ClinicalTrials.gov36/100

Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension

ClinicalTrials.gov study NCT00201201. IPD Sharing: Not stated. Countries: 1. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →
zenodo32/100

Appendix 2 Self-medication study questionnaire

<p>Appendix 2 Self-medication study questionnaire</p>

opencc-by-4.0Jul 2017View details →
zenodo32/100

Appendix 1 Self-medication study questionnaire

<p>Self-medication study questionnaire</p>

opencc-by-4.0Jul 2017View details →
ClinicalTrials.gov28/100

Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

ClinicalTrials.gov study NCT01964404. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt

ClinicalTrials.gov study NCT07273214. IPD Sharing: NO. Countries: 0. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

ClinicalTrials.gov study NCT00946348. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad28/100

Data from: Dynamics of macronutrient self-medication and illness-induced anorexia in virally-infected insects

Open the record for dataset details and reuse information.

publicAug 2013View details →
zenodo24/100

Figure 2 from: Lebanova H, Balkanski S, Naseva E, Getov IN (2020) What does self-medication counseling in Bulgarian community pharmacies look like – a field study. Pharmacia 67(4): 289-293. https://doi.org/10.3897/pharmacia.67.e57752

Figure 2 Patients'sources of information according to the respondents.

opencc-by-4.0Nov 2020View details →
zenodo24/100

Figure 1 from: Lebanova H, Balkanski S, Naseva E, Getov IN (2020) What does self-medication counseling in Bulgarian community pharmacies look like – a field study. Pharmacia 67(4): 289-293. https://doi.org/10.3897/pharmacia.67.e57752

Figure 1 Most common symptoms/conditions for which patients seek advice from the pharmacist.

opencc-by-4.0Nov 2020View details →
zenodo24/100

Figure 4 from: Lebanova H, Balkanski S, Naseva E, Getov IN (2020) What does self-medication counseling in Bulgarian community pharmacies look like – a field study. Pharmacia 67(4): 289-293. https://doi.org/10.3897/pharmacia.67.e57752

Figure 4 Pharmacists'reasons to refer patient to physician.

opencc-by-4.0Nov 2020View details →
zenodo24/100

Figure 3 from: Lebanova H, Balkanski S, Naseva E, Getov IN (2020) What does self-medication counseling in Bulgarian community pharmacies look like – a field study. Pharmacia 67(4): 289-293. https://doi.org/10.3897/pharmacia.67.e57752

Figure 3 Main factors that could prevent pharmacists from providing consultation.

opencc-by-4.0Nov 2020View details →
ClinicalTrials.gov24/100

Medical Follow-up and Self-medication Among Medical Students

ClinicalTrials.gov study NCT05578911. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Exploration of Patient Self-medication Practices During and After Cancer in France

ClinicalTrials.gov study NCT05156931. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner

ClinicalTrials.gov study NCT05412407. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Lifestyle, Self-medication and Use of Nutraceuticals in a Population of Italian and Spanish Students

ClinicalTrials.gov study NCT04099420. IPD Sharing: YES. Countries: 2. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

Prevalence of Self-medication for Dental Conditions by Parents for Their Children

ClinicalTrials.gov study NCT04004780. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

AMO CROC Study: Self-medication and Dental Pain of Pulpal and Peri-apical Origin. Qualitative Study

ClinicalTrials.gov study NCT05808452. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record